Phase II Study of Serplulimab Combined with First-Line Targeted Therapy, Chemotherapy, and Radiation in Advanced Colorectal Cancer
Phase II Study of Serplulimab Combined with First-Line Targeted Therapy, Chemotherapy, and Radiation in Advanced Colorectal Cancer
Recruiting · NCT06521866 · Registry updated 2025-03-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase II Study of Serplulimab Combined with First-Line Targeted Therapy, Chemotherapy, and Radiation in Advanced Colorectal Cancer | Advanced Colorectal Carcinoma; Immunotherapy | Recruiting | Phase 2 | 2025-03-14 | NCT06521866 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fudan University | 653 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Anyang Cancer Hospital | Anyang | China | 5 |
| Fudan University Shanghai Cancer Center | Shanghai | China | 13 |
| Fujian Cancer Hospital | Fuzhou | China | 18 |
| Huai'an Second People's Hospital | Huaian | China | 1 |
| Lanzhou Military Region General Hospital | Lanzhou | China | 1 |
| Qianfoshan Hospital of Shandong Province | Jinan | China | 1 |
| Taian City Central Hospital | Taian | China | 1 |
| The First Affiliated Hospital of Xiamen University | Xiamen | China | 25 |
| The First Affiliated Hospital of Zhengzhou University | Zhengzhou | China | 56 |
| Yunnan Cancer Hospital | Kunming | China | 10 |